I think the market is a bit nervous about pharma and drug discovery stocks at the moment with all the uncertainty in the US related to the current government and what RFK Jr might do. Once some sense of stability has crept back in then things should improve. Will be interesting how Prescient play this out, so far the results look great but they won't be able to take this all the way on current funds. Have they yet articulated a strategy concerning raising money or partnering?
Add to My Watchlist
What is My Watchlist?
